Built at the Internet Archive
Group
Sort By:
Creator
Sort By:
Publisher
Sort By:
Coverage
Sort By:
Citation
Sort By:
Note
Sort By:
Sites for this collection are listed below. Narrow your results at left, or enter a search query below to find a site, specific URL or to search the text of archived webpages.
Page 1 of 1 (5 Total Results)
Sort By:
Description: Strategic planning document and forms.
Loading Wayback Capture Info...
Loading video data...
Subject: Dames, Shannon , Vancouver Island University , Ketamine, Roots to Thrive, Island Health
Group: COVID-19 Research, Health Practitioners, Services, & Authorities
Creator: Dames, Shannon
Publisher: Canadian Institutes of Health Research
Coverage: British Columbia--Nanaimo
Format: Document
Date: 2020-11-20
Description: Vancouver Island University’s (VIU) Research Award Committee is supporting nine COVID-19 research projects that will help gain a better understanding of the virus’s impact on society and how to improve responses for potential future pandemics.
Loading Wayback Capture Info...
Loading video data...
Subject: Vancouver Island University , Lait, Michael, McFarland, Dana, Riedel, Marian, Morden, Marla, Dames, Shannon , Mayes, Lauren, Devereaux, Alana, Weighill, Aggie, Anderson, Gillian
Group: COVID-19 Research, Education, Post Secondary
Creator: Stern, Rachel
Publisher: Vancouver Island University
Coverage: British Columbia--Cowichan Valley, British Columbia--Nanaimo, British Columbia--Powell River, British Columbia--Vancouver Island, British Columbia--Sunshine Coast, British Columbia--North Cowichan
Format: Media release
Date: 2020-07-06
Description: Amid an international pandemic and a worsening mental health crisis, ketamine-assisted therapy is emerging as a promising solution for those deemed “treatment resistant.” Post-traumatic stress disorder (PTSD) and depression are on the rise, with accelerating direct (e.g., burden of suffering) and indirect (e.g., disability/role impairment and impact on family) costs. Psychedelic-assisted therapies show significant promise in the treatment of a number of clinically challenging conditions, including depression, anxiety, PTSD, addiction, and end-of-life distress. Ketamine is currently the only safe, effective and legal widely available psychedelic-like medicine. To address the echo pandemic of health care provider distress, a multi-disciplinary team was charged with developing a ketamine-assisted psychotherapy program, delivered in a community of practice (CoP) group model and evaluated in a quality improvement framework. Program evaluation occurred through mixed methods. Quantitative mental health assessments included the PHQ-9 for depression, the PCL-5 for PTSD, GAD-7 for generalized anxiety disorder (GAD), and B-IPF for work/life functionality. Participant narrative feedback was collected to evaluate outcomes and for quality improvement purposes. Mean mental health scores were collected across three cohorts, totaling 94 patients. The mean aggregate scores of participants meeting the mental health assessment cut-off criteria (screening positive) were analyzed to assess clinical significance. Mean aggregate results comparing baseline vs. outcome measures (measured within 1–2 weeks after completion of the 12-week program) were clinically significant, demonstrating significant improvements in depression, post-traumatic stress disorder, generalized anxiety disorder and work/life functionality. In summary, 91% saw improvements in generalized anxiety, 79% saw improvements in depression, 86% of those who screened positive for PTSD now screen negative, and 92% had significant life/work functionality improvements. Qualitative feedback was overwhelmingly positive, with several unsolicited self-reports of transformation. Participant and team feedback enables the program to continue improving with each iteration. Results speak to the effectiveness of ketamine for psychedelic-assisted therapy, supported by a CoP framework. Outcomes are relevant for mental health programming, education and healthcare policy.
Loading Wayback Capture Info...
Loading video data...
Subject: Ketamine, Vancouver Island University , Watler, Crosbie, Dames, Shannon , Island Health
Group: COVID-19 Research, Education, Post Secondary, Health Practitioners, Services, & Authorities
Creator: Dames, Shannon, Kryskow, Pamela, Watler, Crosbie
Publisher: Vancouver Island University
Coverage: British Columbia--Nanaimo
Format: Article
Date: 2022-01-12
Description: The Roots to Thrive program, run by Shannon Dames, a professor of nursing at Vancouver Island University, was devised to help front-line workers with TRD and PTSD. Ketamine was added to the existing program for its "mind-loosening" effect to "address barriers that are preventing people from living well," she said.
Loading Wayback Capture Info...
Loading video data...
Subject: Hug, Stephanie, Roots to Thrive, Vancouver Island University , Ketamine, Husain, Ishrat, Dames, Shannon , Tobin, Bruce, Wood, Evan
Group: COVID-19 Research, Health Practitioners, Services, & Authorities
Creator: Moran, Padraig
Publisher: CBC | The Current
Coverage: British Columbia--Nanaimo
Format: News media
Date: 2021-03-04
Description: Given high rates of occupational stress, health care workers can be prone to burnout. As COVID continues to place additional strain on care providers, it is critical to highlight the need for care providers to also care for themselves.
Loading Wayback Capture Info...
Loading video data...
Subject: Island Health, Dames, Shannon , Vancouver Island University , Ketamine, Sbotofrankenstein, Uta, Roots to Thrive
Group: Education, Post Secondary, Health Practitioners, Services, & Authorities
Creator: Island Health
Publisher: Eventbrite
Coverage: British Columbia--Vancouver Island
Format: Website content
Date: 2021
Relation: British Columbia--Nanaimo
Page 1 of 1 (5 Total Results)
